Jie
He
Dr. Jie He received his M.D. Degree (Clinical Medicine) in 1984 from the Bethune Medical University in Changchun, China and his Ph.D Degree in Oncology (Thoracic Surgery)in 1993 at the Cancer Hospital of the Chinese Academy of Medical Sciences (CHCAMS) in Beijing, China. Afterwards he did the postdoctoral fellow in the United States from 1995 to 1997. In 1997, he returned to the Department of Thoracic Surgery in CHCAMS and gradually became the Department Deputy Director, Department Director, Deputy Director of CHCAMS and Director of CHCAMS in 2011. In 2013, He was appointed as Executive Director of China National Cancer Center (NCC) by China Ministry of Health. In 2014, he was elected as the Academician, Chinese Academy of Sciences. In 2015, he was formally appointed as President of China National Cancer Center. Meanwhile, he holds the Fellowship of the American College of Surgeons (FACS), the Prestigious Fellowship Ad Hominem of the Royal College of Surgeons of Edinburgh (RCSEd) and Honorary Fellowship of the College of Surgeons of Hong Kong (CSHK). In 2025, He was elected as the member, National Academy of Medicine of the United States.
Dir He has over 30 years’ experience in clinical practice and translational research on the thoracic oncology, particularly on esophageal and lung cancers. He led several national key grants supported by National Natural Science Foundation, Ministry of Science and Technology and Ministry of Health. He also received several national awards including 1st Prize for National Scientific and Technological Development. As the President of China NCC, he is playing the leading role in building the comprehensive network in cancer research, prevention and clinical practice all over China. In particular, he made much effort in cancer prevention and control across China, which established the biggest cancer registry network in the world and increase the 5-year survival rate of cancer patients from 30.9% to 43.7%.